A Race to Rethink Care After a Dire Diagnosis
With the backing of venture capital and well-known tech investors, Synapticure seeks to fill in the gaps in care and research for those with amyotrophic lateral sclerosis.
Source: nytimes.com
Stay updated with breaking news from Thrive Chicago. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
With the backing of venture capital and well-known tech investors, Synapticure seeks to fill in the gaps in care and research for those with amyotrophic lateral sclerosis.
A devastating diagnosis. A fight against time. And an ‘epic’ journey that galvanized a new movement for ALS patients.